Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
HY-100489 |
TBHQ |
|
99.89% |
Unkown |
HY-W010772 |
Bis(tri-tert-butylphosphine)palladium(0) |
|
98.10% |
Unkown |
HY-136177 |
Tris(2,4-di-tert-butylphenyl)phosphate |
Inhibitor |
99.81% |
Unkown |
HY-W007408 |
tert-Butyl 2-aminoacetate |
|
99.64% |
Unkown |
HY-I0172 |
L-tert-Leucine Methyl Ester Hydrochloride |
|
≥98.0% |
Unkown |
HY-W008079 |
(S)-2-Amino-6-((tert-butoxycarbonyl)amino)hexanoic acid |
|
≥98.0% |
Unkown |
HY-Y0134 |
(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid |
|
99.93% |
Unkown |
HY-Y1169 |
Fmoc-Asp(OtBu)-OH |
|
99.84% |
Unkown |
HY-40174A |
N-Boc-N-methylethylenediamine |
|
≥98.0% |
Unkown |
HY-40228 |
(R)-(+)-tert-Butylsulfinamide |
|
99.58% |
Unkown |
HY-42904 |
Potassium tert-butyl malonate |
|
≥95.0% |
Unkown |
HY-W054292 |
tert-Butyl-DCL |
Inhibitor |
≥98.0% |
Unkown |
HY-69260 |
tert-Butyl 4-formylpiperidine-1-carboxylate |
|
99.54% |
Unkown |
HY-W003177 |
tert-Butyl 4-iodopiperidine-1-carboxylate |
|
97.47% |
Unkown |
HY-W014589 |
2,4-Di-tert-butylphenol |
Inhibitor |
99.99% |
Unkown |
HY-W048693 |
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyldimethylsilyl)-L-serine |
|
98.54% |
Unkown |
HY-402361 |
TERT activator-1 |
|
99.50% |
Unkown |
HY-59260 |
N-Boc-L-tert-Leucine |
|
≥98.0% |
Unkown |
HY-40229 |
(S)-(-)-tert-Butylsulfinamide |
|
99.73% |
Unkown |
HY-Y1166 |
N-(9-Fluorenylmethoxycarbonyl)glutamic acid α-tert-butyl ester |
|
99.93% |
Unkown |
HY-40172 |
tert-Butyl (3-aminopropyl)carbamate |
|
99.69% |
Unkown |
HY-W007389 |
4-tert-Butylphenylboronic acid |
|
99.99% |
Unkown |
HY-W018501 |
Methyl p-tert-butylphenylacetate |
|
98.81% |
Unkown |
HY-Z0424 |
(S)-2-[(tert-Butoxycarbonyl)amino]-3-iodopropionic acid methyl ester |
|
99.42% |
Unkown |
HY-W008446 |
(2S,4R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid |
|
99.13% |
Unkown |
HY-128463 |
N-tert-Butyl-α-phenylnitrone |
Inhibitor |
99.94% |
Unkown |
HY-34451 |
Tri-tert-butylphosphine tetrafluoroborate |
|
≥98.0% |
Unkown |
HY-79676 |
Methyl (R)-2-((tert-butoxycarbonyl)amino)-3-iodopropanoate |
|
99.96% |
Unkown |
HY-W248248 |
tert-Butyl 9-aminononanoate |
|
≥98.0% |
Unkown |
HY-Y0978 |
Boc-Glycine |
|
99.81% |
Unkown |
HY-W007573 |
(S)-4-(tert-Butoxy)-3-((tert-butoxycarbonyl)amino)-4-oxobutanoic acid |
|
≥98.0% |
Unkown |
HY-W009110 |
(S)-3-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid |
|
99.73% |
Unkown |
HY-W017330 |
Methacrylic anhydride |
|
97.76% |
Unkown |
HY-41650 |
Boc-Ala-NMe(OMe) |
|
/ |
Unkown |
HY-W006923 |
O-(tert-Butyl)-N-Fmoc-L-allothreonine |
|
99.86% |
Unkown |
HY-W036333 |
N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-(tert-butoxycarbonyl)-N2-methyl-L-lysine |
|
99.75% |
Unkown |
HY-22055B |
AN-12-H5 intermediate-1 |
|
99.72% |
Unkown |
HY-60280 |
Di-tert-butyl iminodicarboxylate |
|
≥98.0% |
Unkown |
HY-75331 |
Glycine tert-butyl ester hydrochloride |
|
≥98.0% |
Unkown |
HY-W002421 |
(R)-3-(Boc-amino)pyrrolidine |
|
99.14% |
Unkown |
HY-W003696 |
tert-Butyl 5-bromoisoindoline-2-carboxylate |
|
98.89% |
Unkown |
HY-W040686 |
2-(Bis(2-(tert-butoxy)-2-oxoethyl)amino)acetic acid |
|
≥97.0% |
Unkown |
HY-Y1167 |
N-tert-Butoxycarbonyl-N-methylalanine |
|
≥98.0% |
Unkown |
HY-130715 |
tert-Butyl 11-aminoundecanoate |
|
99.02% |
Unkown |
HY-20841 |
Boc-(2S)-Gly-4-pyranoyl |
|
≥97.0% |
Unkown |
HY-W000843 |
(2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)butanoic acid |
|
99.75% |
Unkown |
HY-W001954 |
D-a-tert-Butyl-Gly-OH |
|
≥98.0% |
Unkown |
HY-W002410 |
(S)-2-((tert-Butoxycarbonyl)amino)-2-cyclohexylacetic acid |
|
≥98.0% |
Unkown |
HY-W003140 |
tert-Butyl 3-hydroxypyrrolidine-1-carboxylate |
|
99.93% |
Unkown |
HY-W034597 |
20-(tert-Butoxy)-20-oxoicosanoic acid |
|
≥98.0% |
Unkown |
HY-34519 |
(S)-2-Amino-3-(4-hydroxyphenyl)propionic acid tert-butyl ester |
|
99.87% |
Unkown |
HY-40146 |
tert-Butyl 3-oxoazetidine-1-carboxylate |
|
99.99% |
Unkown |
HY-W006185 |
(S)-5-Benzyl 1-tert-butyl 2-aminopentanedioate hydrochloride |
|
≥97.0% |
Unkown |
HY-W008201 |
tert-Butyl 3-formylpyrrolidine-1-carboxylate |
|
99.85% |
Unkown |
HY-W013292 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid |
|
99.73% |
Unkown |
HY-W014258 |
(R)-2-((tert-Butoxycarbonyl)amino)pent-4-ynoic acid |
|
98.27% |
Unkown |
HY-W018528 |
N2,N6-Bis(tert-butoxycarbonyl)-D-lysine |
|
≥95.0% |
Unkown |
HY-W041080 |
3,5-Di-tert-butylphenol |
|
99.97% |
Unkown |
HY-W052246 |
(tert-Butoxycarbonyl)-D-histidine |
|
≥98.0% |
Unkown |
HY-W111214 |
Benzyl (tert-butoxycarbonyl)-L-tyrosinate |
|
96.55% |
Unkown |
HY-W283556 |
DO2A-tert-butyl ester |
|
≥98.0% |
Unkown |
HY-Y1164 |
N-tert-Butoxycarbonyl-D-alanine |
|
99.92% |
Unkown |
HY-113416AS |
Dehydroepiandrosterone sulfate-d6 sodium dihydrate |
|
98.00% |
Unkown |
HY-21577 |
Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine |
|
≥98.0% |
Unkown |
HY-41912 |
Boc-Nle-OH |
|
≥97.0% |
Unkown |
HY-50284 |
N-Boc-indole-2-boronic acid |
|
98.64% |
Unkown |
HY-B1941 |
4-tert-Octylphenol |
|
99.48% |
Unkown |
HY-W002588 |
(R)-3-(4-Bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid |
|
99.48% |
Unkown |
HY-W007500 |
2,6-Di-tert-butyl-4-methylpyridine |
|
99.89% |
Unkown |
HY-W007620 |
(S)-3-(4-Aminophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid |
|
99.48% |
Unkown |
HY-W008134 |
N-tert-Butyloxycarbonyl-L-histidine |
|
99.91% |
Unkown |
HY-W012399 |
2,5-Di-tert-butylhydroquinone |
Modulator |
99.90% |
Unkown |
HY-W014663 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-hydroxypropanoic acid |
|
99.85% |
Unkown |
HY-W022137 |
2-((tert-Butoxycarbonyl)(methyl)amino)propanoic acid |
|
≥97.0% |
Unkown |
HY-W046348 |
22-(tert-Butoxy)-22-oxodocosanoic acid |
|
99.07% |
Unkown |
HY-W053503 |
(S)-3-((tert-Butoxycarbonyl)amino)-3-(3-(trifluoromethyl)phenyl)propanoic acid |
|
99.11% |
Unkown |
HY-Y0621 |
4′-tert-Butylacetophenone |
|
99.74% |
Unkown |
HY-Y1030 |
tert-Butyl L-valinate hydrochloride |
|
≥98.0% |
Unkown |
HY-12692 |
DO3A tert-Butyl ester |
|
≥98.0% |
Unkown |
HY-W009354 |
Di-tert-butyl diisopropylphosphoramidite |
|
96.85% |
Unkown |
HY-W325356 |
tert-Butyl 3,5-dinitrobenzoate |
|
99.71% |
Unkown |
HY-103502 |
CGP7930 |
Modulator |
≥99.0% |
Unkown |
HY-100489R |
TBHQ (Standard) |
|
99.86% |
Unkown |
HY-114818 |
4-(tert-Butyl)-benzhydroxamic Acid |
Antagonist |
99.49% |
Unkown |
HY-30120 |
tert-Butyl N-[(1S,2S)-2-aminocyclohexyl]carbamate |
|
≥97.0% |
Unkown |
HY-34346 |
tert-Butyl (2-hydrazinyl-2-oxoethyl)carbamate |
|
≥95.0% |
Unkown |
HY-44070 |
N-(tert-Butoxycarbonyl)-O-(tert-butyl)-L-threonyl-L-proline |
|
97.05% |
Unkown |
HY-79404 |
N-(Tert-Butoxycarbonyl)-L-neopentylglycine |
|
98.52% |
Unkown |
HY-79680 |
(S)-2-(tert-butoxycarbonylamino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoic acid |
|
99.96% |
Unkown |
HY-79861 |
benzyl (tert-Butoxycarbonyl)-L-leucyl-L-phenylalaninate |
|
/ |
Unkown |
HY-N1506 |
Ganodermanontriol |
|
97.42% |
Unkown |
HY-W002294 |
(tert-Butoxycarbonyl)-D-serine |
|
99.61% |
Unkown |
HY-W006152 |
(S)-Methyl 3-amino-2-((tert-butoxycarbonyl)amino)propanoate hydrochloride |
|
≥98.0% |
Unkown |
HY-W006205 |
(2R,2'R)-Di-tert-butyl 3,3'-disulfanediylbis(2-aminopropanoate) dihydrochloride |
|
≥98.0% |
Unkown |
HY-W008178 |
(R)-2-((tert-Butoxycarbonyl)amino)-3-(tritylthio)propanoic acid |
|
99.87% |
Unkown |
HY-W009008 |
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-(tert-butyl)-L-cysteine |
|
99.52% |
Unkown |
HY-W010156 |
O-(tert-Butyl)-L-serine |
|
≥98.0% |
Unkown |
HY-W011324 |
(S)-2-((tert-Butoxycarbonyl)amino)-4-(cyclohexyloxy)-4-oxobutanoic acid |
|
≥97.0% |
Unkown |
HY-W012133 |
(S)-2-Amino-3-(4-(tert-butoxy)phenyl)propanoic acid |
|
99.89% |
Unkown |
HY-W013108 |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-((tert-butoxycarbonyl)amino)phenyl)propanoic acid |
|
≥98.0% |
Unkown |
HY-W013241 |
(R)-3-(Benzylthio)-2-((tert-butoxycarbonyl)amino)propanoic acid |
|
99.90% |
Unkown |
HY-W013305 |
(S)-2-((tert-Butoxycarbonyl)amino)-5-guanidinopentanoic acid |
|
≥98.0% |
Unkown |
HY-W014259 |
(S)-2-((tert-Butoxycarbonyl)amino)pent-4-ynoic acid |
|
≥97.0% |
Unkown |
HY-W017882 |
(2R,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate |
|
≥98.0% |
Unkown |
HY-W023145 |
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-(tert-butylthio)-L-cysteine |
|
99.91% |
Unkown |
HY-W038703 |
(tert-Butoxycarbonyl)-L-valyl-L-alanine |
|
≥98.0% |
Unkown |
HY-W039758 |
Methyl (tert-butoxycarbonyl)-D-phenylalaninate |
|
99.68% |
Unkown |
HY-W048681 |
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-(4-(tert-butoxy)-4-oxobutyl)-L-cysteine |
|
/ |
Unkown |
HY-W089230 |
Boc-His(Boc)-OH |
|
≥97.0% |
Unkown |
HY-W110126 |
(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid |
|
99.09% |
Unkown |
HY-Y0029 |
Boc-D-Asp-OBzl |
|
99.80% |
Unkown |
HY-Y0533 |
L-Aspartic acid 4-tert-butyl ester |
|
≥98.0% |
Unkown |
HY-132994 |
TVD-0003510 |
|
99.01% |
Unkown |
HY-135380 |
Atorvastatin acetonide tert-butyl ester |
|
99.94% |
Unkown |
HY-135384 |
tert-Buthyl Pitavastatin |
|
98.46% |
Unkown |
HY-153551 |
HBED-CC-tris(tert-butyl ester) |
|
98.42% |
Unkown |
HY-23185 |
N-((Benzyloxy)carbonyl)-O-(tert-butyl)-L-threonine |
|
99.89% |
Unkown |
HY-34018 |
1-Bromo-4-tert-butylbenzene |
|
99.94% |
Unkown |
HY-41048 |
(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate |
|
98.30% |
Unkown |
HY-41060 |
tert-Butoxycarbonyl-D-valine |
|
≥97.0% |
Unkown |
HY-41257A |
N-tert-Butoxycarbonyl-D-tyrosine methyl ester |
|
≥98.0% |
Unkown |
HY-42364 |
Boc-Glu(OMe)-OMe |
|
≥97.0% |
Unkown |
HY-42448 |
tert-Butyl (2S,4R)-4-hydroxy-2-hydroxymethylpyrrolidine-1-carboxylate |
|
≥97.0% |
Unkown |
HY-43973 |
N-(tert-Butoxycarbonyl)-S-butylhomocysteine |
|
99.58% |
Unkown |
HY-75947 |
(S)-tert-butyl 1-hydroxy-3-phenylpropan-2-ylcarbamate |
|
99.94% |
Unkown |
HY-76366 |
(S)-N-Boc-3-hydroxypyrrolidine |
|
99.98% |
Unkown |
HY-77584 |
(2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)non-8-enoyl)-4-hydroxypyrrolidine-2-carboxylic acid |
|
95.87% |
Unkown |
HY-77593 |
(2R,4S)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid |
|
≥98.0% |
Unkown |
HY-77894 |
Ethyl (tert-Butoxycarbonyl)glycinate |
|
99.11% |
Unkown |
HY-78105 |
[(tert-butoxycarbonyl)amino](3-chlorophenyl)acetic acid |
|
98.28% |
Unkown |
HY-79046 |
Boc-L-2-aminobutanoic acid |
|
≥98.0% |
Unkown |
HY-79165 |
(2S)-2-[(tert-Butoxycarbonyl)amino]-3-(3,4-difluorophenyl)propionic acid |
|
98.02% |
Unkown |
HY-79271 |
S-tert-Leucine N-methylamide |
|
≥98.0% |
Unkown |
HY-79295 |
N-BOC-3-Fluoro-D-phenylalanine |
|
99.67% |
Unkown |
HY-79417 |
(S)-N-Methyl-N-methoxy-2-(tert-butoxycarbonylamino)-4-methylpentanamide |
|
/ |
Unkown |
HY-79513 |
(R)-Methyl 2-(tert-butoxycarbonylamino)-3-hydroxypropanoate |
|
≥98.0% |
Unkown |
HY-I0377 |
Boc-D-tert-leucine |
|
≥97.0% |
Unkown |
HY-I0917 |
(tert-Butoxycarbonyl)-D-leucine |
|
99.87% |
Unkown |
HY-RS14375 |
TERT Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-W000924 |
3-(N-Boc-amino)phenylboronic acid |
|
≥97.0% |
Unkown |
HY-W002322 |
tert-Butyl Diethylphosphonoacetate |
|
≥98.0% |
Unkown |
HY-W002680 |
(2R,4R)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate |
|
99.96% |
Unkown |
HY-W003222 |
N-tert-Boc-cis-4-fluoro-L-proline |
|
≥99.0% |
Unkown |
HY-W003321 |
(S)-tert-Butyl 5-oxopyrrolidine-2-carboxylate |
|
≥97.0% |
Unkown |
HY-W003991 |
N-Benzyl-N-Cbz-glycine |
|
≥98.0% |
Unkown |
HY-W004063 |
(S)-3-(Benzyloxy)-2-((tert-butoxycarbonyl)amino)propanoic acid |
|
99.35% |
Unkown |
HY-W005143 |
(S)-2-((tert-Butoxycarbonyl)amino)-5-methoxy-5-oxopentanoic acid |
|
≥98.0% |
Unkown |
HY-W005561 |
H-Dab(Boc)-OMe hydrochloride |
|
/ |
Unkown |
HY-W005846 |
2-((tert-Butoxycarbonyl)amino)-3-(4-chlorophenyl)propanoic acid |
|
≥98.0% |
Unkown |
HY-W007586 |
1-Boc-L-azetidine-2-carboxylic acid |
|
≥95.0% |
Unkown |
HY-W007679 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-nitrophenyl)propanoic acid |
|
99.77% |
Unkown |
HY-W007722A |
tert-Butyl alaninate hydrochloride |
|
≥97.0% |
Unkown |
HY-W007766 |
2-((tert-Butoxycarbonyl)amino)-2-methylpropanoic acid |
|
≥97.0% |
Unkown |
HY-W008261 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-cyclohexylpropanoic acid |
|
≥97.0% |
Unkown |
HY-W009502 |
(tert-Butoxycarbonyl)-L-methionine |
|
≥97.0% |
Unkown |
HY-W009535 |
N-(tert-Butoxycarbonyl)-N-methyl-D-leucine |
|
≥97.0% |
Unkown |
HY-W011537 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoic acid |
|
99.60% |
Unkown |
HY-W011983 |
5-Amino-2-((tert-butoxycarbonyl)amino)-5-oxopentanoic acid |
|
≥98.0% |
Unkown |
HY-W012002 |
Methyl (tert-butoxycarbonyl)-L-leucinate |
|
≥98.0% |
Unkown |
HY-W013686 |
tert-Butyl D-leucinate hydrochloride |
|
≥97.0% |
Unkown |
HY-W014100 |
(R)-2-((tert-Butoxycarbonyl)amino)pentanoic acid |
|
≥97.0% |
Unkown |
HY-W014742 |
(S)-2-Amino-5-(tert-butoxy)-5-oxopentanoic acid |
|
≥98.0% |
Unkown |
HY-W018050 |
(S)-2-((tert-Butoxycarbonyl)amino)pent-4-enoic acid |
|
≥97.0% |
Unkown |
HY-W018628 |
(S)-2-((tert-Butoxycarbonyl)amino)-2-cyclopentylacetic acid |
|
≥97.0% |
Unkown |
HY-W019683 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-ethoxyphenyl)propanoic acid |
|
≥97.0% |
Unkown |
HY-W019684 |
(S)-2-(2-((tert-Butoxycarbonyl)amino)propanamido)acetic acid |
|
≥97.0% |
Unkown |
HY-W021790 |
2-((tert-Butoxycarbonyl)amino)-2-cyclohexylacetic acid |
|
≥97.0% |
Unkown |
HY-W022593 |
(R)-2-((tert-Butoxycarbonyl)(methyl)amino)-3-methylbutanoic acid |
|
≥97.0% |
Unkown |
HY-W040438 |
(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-(3,4-dihydroxyphenyl)propanoate |
|
97.09% |
Unkown |
HY-W040723 |
2-(tert-Butylamino)acetic acid hydrochloride |
|
≥98.0% |
Unkown |
HY-W048334 |
Methyl N6-((benzyloxy)carbonyl)-N2-(tert-butoxycarbonyl)-L-lysinate |
|
≥95.0% |
Unkown |
HY-W048831 |
(tert-Butoxycarbonyl)-L-valyl-L-valine |
|
≥97.0% |
Unkown |
HY-W051093 |
(S)-1-(tert-Butoxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid |
|
≥98.0% |
Unkown |
HY-W088097 |
N-Fmoc-4-(tert-butoxycarbonylmethoxy)-L-phenylalanine |
|
≥98.0% |
Unkown |
HY-W089233 |
Boc-D-Glu-OtBu |
|
≥97.0% |
Unkown |
HY-W127622 |
NDSB 256-4T |
|
99.62% |
Unkown |
HY-W140881 |
(3R,4R)-4-(benzyloxy)-3-((tert-butoxycarbonyl)amino)pentanoic acid |
|
/ |
Unkown |
HY-WAA0112 |
Ethyl 2-((2-((tert-butoxycarbonyl)amino)ethyl)amino)acetate hydrochloride |
|
≥97.0% |
Unkown |
HY-Y0028 |
(S)-2-(tert-Butoxycarbonylamino)succinic acid benzyl ester |
|
98.35% |
Unkown |
HY-Y1778 |
N-(Diphenylmethylene)glycine tert-butyl ester |
|
99.96% |
Unkown |
HY-Y1856 |
N-(tert-Butoxycarbonyl)-N-methyl-D-alanine |
|
≥97.0% |
Unkown |
HY-Z0790 |
(R)-3-(3-Bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid |
|
98.18% |
Unkown |
HY-153551A |
HBED-CC-tris(tert-butyl ester) TFA |
|
/ |
Unkown |
HY-W012187 |
3,5-Di-tert-butyl-4-hydroxybenzaldehyde |
|
99.81% |
Unkown |
HY-W024365 |
3-tert-Butyl-4-methoxyphenol |
|
99.69% |
Unkown |
HY-32208S |
tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate-d4 |
|
/ |
Unkown |
HY-100832A |
UNC3866 TFA |
Inhibitor |
/ |
Unkown |
HY-118077 |
RE 11775 |
|
/ |
Unkown |
HY-128463S |
N-tert-Butyl-α-phenylnitrone-d14 |
|
/ |
Unkown |
HY-133830 |
7α,24(S)-Dihydroxycholesterol |
|
/ |
Unkown |
HY-133887 |
Methotrexate α-tert-butyl ester |
Inhibitor |
≥96.0% |
Unkown |
HY-135380R |
Atorvastatin acetonide tert-butyl ester (Standard) |
|
/ |
Unkown |
HY-135587 |
4'-tert-Butyldimethylsilyl-6-hydroxy Raloxifene |
|
/ |
Unkown |
HY-140347 |
APN-C3-NH-Boc |
|
/ |
Unkown |
HY-149303 |
Potassium tert-butoxide |
|
/ |
Unkown |
HY-151083S |
2-tert-Butylamino-d9-4-chloro-6-cyclopropylamino-1,3,5-triazine |
|
/ |
Unkown |
HY-154276 |
1-O-Acetyl-2-O-benzoyl-3-O-tert-butyldiphenylsilyl-L-threofuranose |
|
/ |
Unkown |
HY-154309 |
3'-O-tert-Butyldimethylsilyl-5'-O-DMT-2'-deoxyadenosine |
|
/ |
Unkown |
HY-154391 |
5-O-(tert-Butyldiphenylsilyl)-2,3-isopropylidene-D-ribonolactone |
|
/ |
Unkown |
HY-154419 |
N6-Benzoyl-2'-O-tert-butyldimethylsilyl-3'-O-DMT-adenosine |
|
/ |
Unkown |
HY-154647 |
N3-(2S)-[2-(tert-Butoxycarbonyl)amino-3-(tert-butoxy carbonyl)]propyluridine |
|
/ |
Unkown |
HY-154724 |
2’-Deoxy-2’-fluoro-N3-(2S)-[2-(tert-butoxy-carbonyl)-amino-3-carbonyl]propyluridine |
|
/ |
Unkown |
HY-154725 |
2’-Deoxy-2’-fluoro-N3-[3-(tert-butoxycarbonyl) amino]propyluridine |
|
/ |
Unkown |
HY-154738 |
N3-[3-(tert-Butoxycarbonyl)amino]propyluridine |
|
/ |
Unkown |
HY-159651 |
PTOTAC HSD17B13 degrader 1 |
|
/ |
Unkown |
HY-161958 |
dCE-2 |
|
/ |
Unkown |
HY-162568 |
7-tert-Butylfascaplysin |
|
/ |
Unkown |
HY-162816 |
PROTAC HPK1 Degrader-3 |
|
/ |
Unkown |
HY-163012 |
Dicamba-6-amino-6-oxohexanoic acid |
|
/ |
Unkown |
HY-164272 |
2'-O-TBDMS-Paclitaxel |
|
/ |
Unkown |
HY-34663 |
(αR)-α-[[(1,1-Dimethylethoxy)carbonyl]amino]benzeneacetic acid |
|
99.30% |
Unkown |
HY-42067 |
(tert-Butoxycarbonyl)-D-aspartic acid |
|
≥98.0% |
Unkown |
HY-42994 |
tert-Butyl (R)-N-benzyl-N-(2-chloropropyl)glycinate |
|
≥95.0% |
Unkown |
HY-76205 |
2-(tert-butoxycarbonylamino)-3-phenylpropanoic acid |
|
≥98.0% |
Unkown |
HY-76929S |
tert-Butyl 4-aminobenzoate-13C6 |
|
/ |
Unkown |
HY-79288 |
(2S)-2-[(tert-Butoxycarbonyl)amino]-3-(3-fluorophenyl)propionic acid |
|
≥95.0% |
Unkown |
HY-N2867 |
Andrographiside |
|
/ |
Unkown |
HY-N2996 |
Ganodermanondiol |
Inhibitor |
/ |
Unkown |
HY-N9535 |
tert-OMe-byakangelicin |
|
/ |
Unkown |
HY-N9535A |
(R)-tert-OMe-byakangelicin |
|
/ |
Unkown |
HY-RS14376 |
Tert Mouse Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-RS14377 |
Tert Rat Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-W000830 |
tert-Butyl 2-((tert-butoxycarbonyl)amino)acetate |
|
/ |
Unkown |
HY-W002327S |
Fmoc-Asn(Trt)-OH-13C4,15N2 |
|
/ |
Unkown |
HY-W002449 |
N2-(tert-Butoxycarbonyl)-N4-trityl-L-asparagine |
|
99.20% |
Unkown |
HY-W004153 |
S-(Acetamidomethyl)-N-(tert-butoxycarbonyl)-L-cysteine |
|
98.18% |
Unkown |
HY-W004861 |
2-((tert-Butoxycarbonyl)amino)-3-methylbutanoic acid |
|
≥98.0% |
Unkown |
HY-W008489 |
(R)-2-((tert-Butoxycarbonyl)amino)-3-(naphthalen-2-yl)propanoic acid |
|
99.52% |
Unkown |
HY-W008667 |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid hydrate |
|
99.49% |
Unkown |
HY-W009197 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(naphthalen-1-yl)propanoic acid |
|
99.45% |
Unkown |
HY-W009257 |
Benzyl (tert-butoxycarbonyl)-D-serinate |
|
96.94% |
Unkown |
HY-W009322 |
(R)-2-((tert-Butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoic acid |
|
99.49% |
Unkown |
HY-W009648 |
O-tert-Butylthreoninetert-butyl ester |
|
99.89% |
Unkown |
HY-W010037S |
2-(tert-Butyl)-4-methoxyphenol-d3 |
|
/ |
Unkown |
HY-W010216S |
4-(tert-Butyl)cyclohexanone-d9 |
|
/ |
Unkown |
HY-W010913 |
(S)-2-((tert-Butoxycarbonyl)amino)-5-(3-tosylguanidino)pentanoic acid |
|
/ |
Unkown |
HY-W011049 |
(S)-6-(((Benzyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)hexanoic acid |
|
≥98.0% |
Unkown |
HY-W011218 |
(R)-2-((tert-Butoxycarbonyl)amino)-3-(3,4-dichlorophenyl)propanoic acid |
|
≥97.0% |
Unkown |
HY-W011223 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-(trifluoromethyl)phenyl)propanoic acid |
|
97.64% |
Unkown |
HY-W011322 |
(R)-2-((tert-Butoxycarbonyl)amino)-3-(naphthalen-1-yl)propanoic acid |
|
/ |
Unkown |
HY-W011354 |
O-tert-Butyl-N-carbobenzoxy-L-serine methyl ester |
|
/ |
Unkown |
HY-W011652 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(thiophen-2-yl)propanoic acid |
|
≥95.0% |
Unkown |
HY-W011886S |
N2-(tert-Butyl)-N4-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine-d9 |
|
/ |
Unkown |
HY-W012482 |
5-(tert-Butyl)isobenzofuran-1,3-dione |
|
96.02% |
Unkown |
HY-W013638 |
tert-Butyl 2-(methylamino)acetate |
|
/ |
Unkown |
HY-W013810 |
(tert-Butoxycarbonyl)-L-arginine hydrochloride |
|
≥97.0% |
Unkown |
HY-W014238 |
S-tert-Butyl-L-cysteine hydrochloride |
|
≥98.0% |
Unkown |
HY-W014663S |
(S)-2-((tert-Butoxycarbonyl)amino)-3-hydroxypropanoic acid-d3 |
|
/ |
Unkown |
HY-W016035 |
(R)-3-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid |
|
/ |
Unkown |
HY-W016730S |
tert-Butyl (1-hydroxypropan-2-yl)carbamate-d6 |
|
/ |
Unkown |
HY-W017145S |
4-(tert-Butyl)benzene-1,2-diol-d12 |
|
/ |
Unkown |
HY-W017187 |
2-tert-Butyl-1,4-benzoquinone |
Inducer |
97.75% |
Unkown |
HY-W017199S |
N-Benzyl-2-methylpropan-2-amine-d9 |
|
/ |
Unkown |
HY-W017456S |
4-(tert-Butyl)aniline-d15 |
|
/ |
Unkown |
HY-W022138 |
N-Tert-Butoxycarbonyl-(4S)-4-Methoxymethyl-L-proline |
|
≥95.0% |
Unkown |
HY-W022536 |
(R)-Ethyl 2-((tert-butoxycarbonyl)amino)-3-hydroxypropanoate |
|
≥97.0% |
Unkown |
HY-W022630 |
2-((tert-Butoxycarbonyl)amino)-2-cyclobutylacetic acid |
|
≥95.0% |
Unkown |
HY-W024365S |
2-tert-Butyl-4-hydroxyanisole-d3 |
|
/ |
Unkown |
HY-W025811 |
1-(tert-Butyl) 5-methyl L-glutamate hydrochloride |
|
≥97.0% |
Unkown |
HY-W030321 |
((4-(tert-Butyl)phenyl)sulfonyl)phenylalanine |
|
/ |
Unkown |
HY-W039180 |
Methyl (tert-butoxycarbonyl)-D-leucinate |
|
≥97.0% |
Unkown |
HY-W039695 |
(tert-Butoxycarbonyl)-L-valylglycine |
|
≥97.0% |
Unkown |
HY-W039759 |
(tert-Butoxycarbonyl)-L-leucylglycine |
|
/ |
Unkown |
HY-W042009A |
(R)-Phenylglycine tert-butyl ester hydrochloride |
|
≥97.0% |
Unkown |
HY-W048839 |
N-(tert-Butoxycarbonyl)-N-methyl-L-threonine |
|
/ |
Unkown |
HY-W052309 |
(tert-Butoxycarbonyl)methionine |
|
≥95.0% |
Unkown |
HY-W053801 |
tert-Butyl benzylglycinate |
|
/ |
Unkown |
HY-W057434 |
Methyl N-(tert-butoxycarbonyl)-O-methyl-L-serinate |
|
≥97.0% |
Unkown |
HY-W072598 |
N-(tert-Butoxycarbonyl)-O-(tetrahydro-2H-pyran-2-yl)-L-serine |
|
/ |
Unkown |
HY-W077436S |
2,6-Di-(tert-butyl)-4-methoxyphenol-3,5-d20 |
|
/ |
Unkown |
HY-W101713 |
3-(Maleimidopropane-1-carbonyl-1-(tert-butyl)carbazate |
|
/ |
Unkown |
HY-W112276 |
meso-Tetra(4-tert-butylphenyl) porphine |
|
/ |
Unkown |
HY-W127827 |
5,10,15-Tris(4-tert-butylphenyl) corrole |
|
/ |
Unkown |
HY-W127846 |
4',4''(5'')-Di-tert-butyldibenzo-18-crown-6 |
|
/ |
Unkown |
HY-W141791 |
S-tert-Butylmercapto-L-cysteine |
|
/ |
Unkown |
HY-W243914S |
tert-Butylamine-d9Hydrobromide |
|
/ |
Unkown |
HY-W283336S |
2,5-Di-(tert-butyl)-4-methoxyphenol-3,6-d20 |
|
/ |
Unkown |
HY-W436472 |
6-O-(tert-Butyldimethylsilyl)-D-galactal |
|
/ |
Unkown |
HY-W454729S |
tert-Butyl 4-hydroxypiperidine-1-carboxylate-3,3,4,5,5-d5 |
|
/ |
Unkown |
HY-W505469 |
6-O-(tert-Butyldimethylsilyl)-D-glucal |
|
/ |
Unkown |
HY-W701862 |
5-Azido-6-(tert-butyldimethylsilyl)-2,3-O-isopropylidene L-gulono-1,4-lactone |
|
/ |
Unkown |
HY-W739717 |
3-O-tert-Butyldimethylsilyl-D-erythro-sphingosylphosphorylcholine |
|
/ |
Unkown |
HY-W739797 |
4,6-O-Benzylidene-N-(tert-butoxycarbonyl)-1,5-imino-D-glucitol |
|
/ |
Unkown |
HY-W800843 |
tert-Butyl 3-(7-((undecan-3-yloxy)carbonyl)heptylamino)propylcarbamate |
|
/ |
Unkown |
HY-Y0920 |
tert-Butoxycarbonyl-DL-alanine |
|
≥98.0% |
Unkown |
HY-Y0978S2 |
Boc-Glycine-2-13C |
Antagonist |
/ |
Unkown |
HY-Y1169S1 |
Fmoc-Asp(OtBu)-OH-13C4,15N |
|
/ |
Unkown |
HY-Z0615 |
(2S)-4-(Benzyloxy)-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoic acid |
|
99.92% |
Unkown |
HY-106514 |
Prifelone |
Inhibitor |
/ |
Unkown |
HY-132350S |
iso-Nadolol (tert-Butyl-d9) |
|
/ |
Unkown |
HY-164271 |
10-Boc-SN-38 |
Inhibitor |
/ |
Unkown |
HY-43066 |
DMT-2'-O-TBDMS-G(dmf)-CE-phosphoramidite |
|
/ |
Unkown |
HY-79491S |
(S)-2-Aminobutyramide-d3 hydrochloride |
|
/ |
Unkown |
HY-B0130AS |
Perindopril-d3 erbumine |
|
/ |
Unkown |
HY-B1941S1 |
4-tert-Octylphenol-13C6 |
|
/ |
Unkown |
HY-W010037 |
2-(tert-Butyl)-4-methoxyphenol |
Inhibitor |
≥95.0% |
Unkown |
HY-W035599 |
Ir[p-F(t-Bu)-ppy]3 |
|
/ |
Unkown |
HY-W050151 |
2,5-Di-tert-butyl-1,4-benzoquinone |
|
99.78% |
Unkown |
HY-W099352 |
(2R,3S)-3-(tert-Butoxy)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)butanoic acid |
|
/ |
Unkown |
HY-W190972 |
3-(3-Nitrophenyl)-5-phenyl-1,2,4-oxadiazole |
|
/ |
Unkown |
HY-W241345 |
DOTA-bis(tert-butyl)ester |
|
/ |
Unkown |
HY-W251143 |
N,N′-Bis(2,5-di-tert-butylphenyl)-3,4,9,10-perylenedicarboximide |
|
/ |
Unkown |
HY-W777581 |
4-tert-Octylphenol-diethoxylate-13C6 |
|
/ |
Unkown |
HY-W777582 |
4-tert-Octylphenol monoethoxylate-13C6 |
|
/ |
Unkown |
HY-N10351 |
27-O-(tert-Butyldimethylsilyl)withaferin A |
Inducer |
/ |
Unkown |